{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:32:54Z","timestamp":1783128774719,"version":"3.54.6"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review summarizes important mouse models of psoriatic arthritis (PsA), shedding light on their advantages and disadvantages in modeling human disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Two newly created mouse models of PsA validate NF-\u03baB signaling as disease-causing and identify pathogenic roles for CD8<jats:sup>+<\/jats:sup> and CD4<jats:sup>+<\/jats:sup>FoxP3<jats:sup>+<\/jats:sup>T cells in the development of specific PsA phenotypes. The <jats:italic toggle=\"yes\">Ikbkb<\/jats:italic>\n                                 <jats:sup>GoF\/GoF<\/jats:sup> model demonstrates that homozygosity for a gain-of-function mutation in <jats:italic toggle=\"yes\">Ikbkb<\/jats:italic> results in expansion of FoxP3<jats:sup>+<\/jats:sup>CD25<jats:sup>+<\/jats:sup>IL-17A<jats:sup>+<\/jats:sup> Tregs that lead to the development of dactylitis, spondylitis and PsA-like changes to the nails and skin, and when transferred to wildtype mice, reproduce these outcomes. The humanized mouse PsA model (Hu-PsA) establishes that introduction of PsA patient sera and PBMCs into NSG-SGM3 mice has the capacity to elicit distinct subtypes of PsA and identifies a critical role for CD8<jats:sup>+<\/jats:sup>IL-32<jats:sup>+<\/jats:sup>CXCL14<jats:sup>+<\/jats:sup> T cells and immunoglobulins in disease development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Mouse models of PsA are powerful research tools for elucidating pathogenesis of disease, biomarker identification and may assist in the discovery of a cure.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001093","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T09:01:13Z","timestamp":1745398873000},"page":"243-253","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["What are mice teaching us about psoriatic arthritis?"],"prefix":"10.1097","volume":"37","author":[{"given":"Peggy M.","family":"Randon","sequence":"first","affiliation":[{"name":"Medical Scientist Training Program, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann E.","family":"Gudjonsson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Dermatology"},{"name":"Vanderbilt Institute for Infection, Immunology, and Inflammation (VI4) and Vanderbilt Center for Immunobiology (VCI), Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"(Suppl 2)","key":"R1-20250604","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaad.2008.02.040","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics","volume":"58","author":"Gottlieb","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","article-title":"Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison","volume":"14","author":"Feld","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2004.024463","article-title":"A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis","volume":"64","author":"Fraser","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R6-20250604","first-page":"2274","article-title":"A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis","volume":"28","author":"Salvarani","year":"2001","journal-title":"J Rheumatol"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2133.1996.tb03885.x","article-title":"Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis. A prospective multicentre study","volume":"135","author":"Mahrle","year":"1996","journal-title":"Br J Dermatol"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","article-title":"Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis","volume":"74","author":"Mease","year":"2014","journal-title":"Drugs"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3899\/jrheum.110242","article-title":"Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial","volume":"38","author":"Karanikolas","year":"2011","journal-title":"J Rheumatol"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","article-title":"Psoriatic arthritis from a mechanistic perspective","volume":"18","author":"Schett","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12016-012-8303-5","article-title":"The genetics of psoriasis and psoriatic arthritis","volume":"44","author":"Chandran","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"Am J Hum Genet"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1030256","DOI":"10.1155\/2019\/1030256","article-title":"Gene variant in the NF-\u03baB pathway inhibitor NFKBIA distinguishes patients with psoriatic arthritis within the spectrum of psoriatic disease","volume":"2019","author":"Coto-Segura","year":"2019","journal-title":"Biomed Res Int"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1038\/s41467-018-06672-6","article-title":"Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients","volume":"9","author":"Patrick","year":"2018","journal-title":"Nat Commun"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1038\/s41598-020-65269-6","article-title":"Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice","volume":"10","author":"Chen","year":"2020","journal-title":"Sci Rep"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1096\/fj.201900420R","article-title":"Adenoviral gene transfer of a single-chain IL-23 induces psoriatic arthritis-like symptoms in NOD mice","volume":"33","author":"Flores","year":"2019","journal-title":"FASEB J"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1093\/rheumatology\/kead022","article-title":"ROR\u03b3t inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating \u03b3\u03b4-T cells","volume":"62","author":"Mortier","year":"2023","journal-title":"Rheumatology"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4049\/jimmunol.1003986","article-title":"IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass","volume":"187","author":"Adamopoulos","year":"2011","journal-title":"J Immunol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/1346-8138.14899","article-title":"Characterization of psoriasiform dermatitis induced by systemic injection of interleukin-23 minicircles in mice","volume":"46","author":"Leys","year":"2019","journal-title":"J Dermatol"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4049\/jimmunol.1601346","article-title":"Critical role of LTB4\/BLT1 in IL-23-induced synovial inflammation and osteoclastogenesis via NF-\u03baB","volume":"198","author":"Bouchareychas","year":"2017","journal-title":"J Immunol"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39732","article-title":"Interleukin-23-dependent \u03b3\/\u03b4 T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice","volume":"68","author":"Reinhardt","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/art.42124","article-title":"Peripheral \u03b3\u03b4 T cells regulate neutrophil expansion and recruitment in experimental psoriatic arthritis","volume":"74","author":"Nguyen","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/art.42478","article-title":"Interleukin-23 regulates inflammatory osteoclastogenesis via activation of CLEC5A(+) osteoclast precursors","volume":"75","author":"Furuya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/jid.2014.426","article-title":"Psoriatic inflammation facilitates the onset of arthritis in a mouse model","volume":"135","author":"Yamamoto","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/art.40447","article-title":"Augmented Th17 differentiation leads to cutaneous and synovio-entheseal inflammation in a novel model of psoriatic arthritis","volume":"70","author":"Yang","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"758418","DOI":"10.3389\/fimmu.2021.758418","article-title":"High dimensional analyses of circulating immune cells in psoriatic arthritis detects elevated phosphorylated STAT3","volume":"12","author":"Macaubas","year":"2021","journal-title":"Front Immunol"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"E3669","DOI":"10.1073\/pnas.1405798111","article-title":"Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice","volume":"111","author":"Khmaladze","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3390\/antiox12071348","article-title":"Human NCF1(90H) variant promotes IL-23\/IL-17-dependent mannan-induced psoriasis and psoriatic arthritis","volume":"12","author":"Li","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing alphabeta T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J Clin Invest"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/art.41271","article-title":"Interleukin-17A is produced by CD4+ but not CD8+ T cells in synovial fluid following T cell receptor activation and regulates different inflammatory mediators compared to tumor necrosis factor in a model of psoriatic arthritis synovitis","volume":"72","author":"Xu","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/annrheumdis-2018-214138","article-title":"Association of synovial tissue polyfunctional T-cells with DAPSA in psoriatic arthritis","volume":"78","author":"Wade","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1136\/annrheumdis-2019-216658","article-title":"Polyfunctional TEM cells in psoriatic arthritis synovium skewed towards Th17 cells","volume":"81","author":"Raychaudhuri","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/jid.2013.404","article-title":"IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions","volume":"134","author":"Croxford","year":"2014","journal-title":"J Invest Dermatol"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/ATVBAHA.114.304108","article-title":"Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease","volume":"34","author":"Karbach","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"ra337","DOI":"10.1126\/scitranslmed.aad8996","article-title":"Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts","volume":"8","author":"Ulu\u00e7kan","year":"2016","journal-title":"Sci Transl Med"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/art.39282","article-title":"Review: animal models as a tool to dissect pivotal pathways driving spondyloarthritis","volume":"67","author":"Vieira-Sousa","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/art.38026","article-title":"Doxycycline-induced expression of transgenic human tumor necrosis factor \u03b1 in adult mice results in psoriasis-like arthritis","volume":"65","author":"Retser","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/rheumatology\/kev296","article-title":"HLA-B27 and psoriatic disease: a modern view of an old relationship","volume":"55","author":"Queiro","year":"2015","journal-title":"Rheumatology"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0092-8674(90)90512-D","article-title":"Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders","volume":"63","author":"Hammer","year":"1990","journal-title":"Cell"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.2112266","article-title":"Normal development of mice deficient in beta 2\u200aM, MHC class I proteins, and CD8+ T cells","volume":"248","author":"Koller","year":"1990","journal-title":"Science"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1084\/jem.172.4.1255","article-title":"Expression of HLA-B27 in transgenic mice is dependent on the mouse H-2D genes","volume":"172","author":"Nickerson","year":"1990","journal-title":"J Exp Med"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1084\/jem.182.4.1153","article-title":"Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies","volume":"182","author":"Khare","year":"1995","journal-title":"J Exp Med"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4161\/pri.3.1.8072","article-title":"HLA-B27 misfolding and spondyloarthropathies","volume":"3","author":"Colbert","year":"2009","journal-title":"Prion"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4419-0298-6_19","article-title":"T-cell responses against viral and self-epitopes and HLA-B27 subtypes differentially associated with ankylosing spondylitis","volume":"649","author":"Fiorillo","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/BOR.0000000000000720","article-title":"MHC class I associations beyond HLA-B27: the peptide binding hypothesis of psoriatic arthritis and its implications for disease pathogenesis","volume":"32","author":"Winchester","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"e178213","DOI":"10.1172\/jci.insight.178213","article-title":"Psoriatic arthritis subtypes are phenocopied in humanized mice","volume":"9","author":"Ritchlin","year":"2024","journal-title":"JCI Insight"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41590-020-0634-4","article-title":"Noncatalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation","volume":"21","author":"Razani","year":"2020","journal-title":"Nat Immunol"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"103914","DOI":"10.1016\/j.cellimm.2019.04.002","article-title":"A20: a multifunctional tool for regulating immunity and preventing disease","volume":"340","author":"Malynn","year":"2019","journal-title":"Cell Immunol"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ai.2020.10.001","article-title":"Preserving immune homeostasis with A20","volume":"148","author":"Razani","year":"2020","journal-title":"Adv Immunol"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1038\/emboj.2012.241","article-title":"Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-\u03baB regulation","volume":"31","author":"Tokunaga","year":"2012","journal-title":"EMBO J"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1038\/s41467-024-45870-3","article-title":"IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model","volume":"15","author":"Cardinez","year":"2024","journal-title":"Nat Commun"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"101494","DOI":"10.1016\/j.berh.2020.101494","article-title":"The gut microbiome in psoriasis and psoriatic arthritis","volume":"33","author":"Myers","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jid.2020.11.032","article-title":"Short-term western diet intake promotes IL-23\u2013mediated skin and joint inflammation accompanied by changes to the gut microbiota in mice","volume":"141","author":"Shi","year":"2021","journal-title":"J Invest Dermatol"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.42765","article-title":"Mitigation of osteoclast-mediated arthritic bone remodeling by short chain fatty acids","volume":"76","author":"Yang","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"103394","DOI":"10.1016\/j.jaut.2025.103394","article-title":"Sex differences in biomarkers and biologic mechanisms in psoriatic diseases and spondyloarthritis","volume":"152","author":"Dang","year":"2025","journal-title":"J Autoimmun"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41584-022-00810-7","article-title":"Sex- and gender-related differences in psoriatic arthritis","volume":"18","author":"Tarannum","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"e0247149","DOI":"10.1371\/journal.pone.0247149","article-title":"The impact of genetic background and sex on the phenotype of IL-23 induced murine spondyloarthritis","volume":"16","author":"Haley","year":"2021","journal-title":"PLoS One"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1172\/JCI133159","article-title":"KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease","volume":"130","author":"Billi","year":"2020","journal-title":"J Clin Invest"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","article-title":"Psoriatic arthritis","volume":"7","author":"FitzGerald","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3899\/jrheum.180796","article-title":"Psoriatic nail dystrophy is associated with erosive disease in the distal interphalangeal joints in psoriatic arthritis: a retrospective cohort study","volume":"46","author":"Antony","year":"2019","journal-title":"J Rheumatol"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3899\/jrheum.190923","article-title":"Association of nail psoriasis with disease activity measures and impact in psoriatic arthritis: data from the Corrona Psoriatic Arthritis\/Spondyloarthritis Registry","volume":"48","author":"Mease","year":"2021","journal-title":"J Rheumatol"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jid.2017.09.021","article-title":"Protection from psoriasis-related thrombosis after inhibition of IL-23 or IL-17A","volume":"138","author":"Li","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"e89384","DOI":"10.1172\/jci.insight.89384","article-title":"Interleukin 6 regulates psoriasiform inflammation-associated thrombosis","volume":"1","author":"Wang","year":"2016","journal-title":"JCI Insight"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/jid.2012.112","article-title":"Chronic skin-specific inflammation promotes vascular inflammation and thrombosis","volume":"132","author":"Wang","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"(3 Pt B)","key":"R66-20250604","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","article-title":"Mouse models of psoriasis: a comprehensive review","volume":"142","author":"Gangwar","year":"2022","journal-title":"J Invest Dermatol"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI85738","article-title":"RAC1 activation drives pathologic interactions between the epidermis and immune cells","volume":"126","author":"Winge","year":"2016","journal-title":"J Clin Invest"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"97179","DOI":"10.1172\/jci.insight.97179","article-title":"Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis","volume":"3","author":"Baumer","year":"2018","journal-title":"JCI Insight"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/annrheumdis-2022-222229","article-title":"Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease","volume":"81","author":"Mellor","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature03963","article-title":"Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins","volume":"437","author":"Zenz","year":"2005","journal-title":"Nature"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/art.41272","article-title":"Therapeutic effects of anti-bone morphogenetic protein and activin membrane-bound inhibitor treatment in psoriasis and arthritis","volume":"72","author":"Alvarez","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R72-20250604","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-024-02134-y","article-title":"EDIL3 alleviates Mannan-induced psoriatic arthritis by slowing the intracellular glycolysis process in mononuclear-derived dendritic cells","author":"Yu","year":"2024","journal-title":"Inflammation"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"8559","DOI":"10.3390\/ijms23158559","article-title":"Phospholipase A1 member A deficiency alleviates mannan-induced psoriatic arthritis in mice model","volume":"23","author":"Zhao","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"eaas9864","DOI":"10.1126\/sciadv.aas9864","article-title":"Mannan-induced Nos2 in macrophages enhances IL-17-driven psoriatic arthritis by innate lymphocytes","volume":"4","author":"Zhong","year":"2018","journal-title":"Sci Adv"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jid.2021.10.027","article-title":"Bile acids improve psoriasiform dermatitis through inhibition of IL-17A expression and CCL20-CCR6-mediated trafficking of T cells","volume":"142","author":"Shi","year":"2022","journal-title":"J Invest Dermatol"},{"key":"R76-20250604","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1038\/s41598-018-25988-3","article-title":"\u03b3\u03b4TCR regulates production of interleukin-27 by neutrophils and attenuates inflammatory arthritis","volume":"8","author":"Bouchareychas","year":"2018","journal-title":"Sci Rep"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:00:28Z","timestamp":1749013228000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001093","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}